 |
Healthcare watchdog pledges to take tough action over infection control failures
|
|
The Healthcare Commission has pledged to continue tough action in NHS trusts that are failing to put adequate systems in place to tackle healthcare-associated infections. |
|
|
Healthcare Commission declares NHS performance is improving
|
|
The Healthcare Commission has published performance ratings for all NHS trusts in England, showing overall improvement in quality of services and use of resources. |
|
|
Rapid result gram positive microbiology tests receive FDA clearance
|
|
Dade Behring has received clearance from the US Food and Drug Administration (FDA) for use of its MicroScan Synergies plus Gram-positive panels. |
|
|
Cepheid licences Quantovir’s HPV portfolio
|
|
Cepheid has entered into an agreement to exclusively licence the Human Papillomavirus (HPV) patent portfolio held by Quantovir of Sweden for the quantitative measurement of high-risk HPV types using DNA-based detection. |
|
|
Cepheid's Xpert MRSA test helps detect HAI cases
|
|
The US Food and Drug Administration (FDA) has categorised Cepheid's Xpert MRSA test for the rapid detection of of Methicillin-Resistant Staphylococcus aureus as 'Moderate Complexity'. |
|
|
US MRSA survey indicates major problems
|
|
The USA’s first nationwide study of the prevalence of MRSA has shown that MRSA is eight times more prevalent than previously thought. |
|
|
Healthcare Commission prepares to inspect 120 NHS trusts unannounced
|
|
The Healthcare Commission is planning to carry out unannounced inspections at 120 NHS trusts during the coming year in what is the biggest ever programme of visits relating to healthcare-associated infection.
|
|
|
Cardinal Health introduce MRSA Scoreboard to give hospital-wide MRSA monitoring
|
|
Cardinal Health has introduced a new service to help hospitals combat methicillin-resistant staphylococcus aureus (MRSA) infections that are responsible for an estimated 94,000 life-threatening conditions and 18,650 deaths annually in the USA. |
|
|
Cardinal Health support IHI campaign for public and rural hospitals
|
|
Cardinal Health Foundation is granting up to $500,000 to hospitals that enroll and report their data to the 5 Million Lives Campaign being run by the Institute for Healthcare Improvement (IHI). |
|
|
New digital hand hygiene reminder device reduces MRSA exposure
|
|
Adroit Global Technologies has developed a novel digital hand hygiene reminder device for use in any area where washing is essential. |
|
|
Birmingham's Royal Orthopaedic Hospital plans to use silver antimicrobial technology to combat MRSA
|
|
The Royal Orthopaedic Hospital in Birmingham has purchased a number of products designed with silver antimicrobial technology that can help reduce the presence of 'superbugs’ such as MRSA. |
|
|
Accelerated hydrogen peroxide cleaning agent helps combat norovirus outbreaks
|
|
Oxivir from JohnsonDiversey has been proven to be highly effective against norovirus and other infections including MRSA, E Coli, SARS, Hepatitis C. |
|
|
New washbowl aims to combat hospital infections
|
|
Trafford General Hospital has become one of the first hospitals in the UK to introduce the new single use Vernacare's Vernaclean washbowl. |
|
|
Cepheid group purchasing contract with Broadlane for molecular diagnostic tests
|
|
Cepheid has signed a group purchasing contract with Broadlane that will enable Broadlane customers to take advantage of Cepheid's molecular diagnostic instruments, reagents and services for its GeneXpert System and Xpert line of tests, including Xpert MRSA. |
|
|
Swedish trials on nitric oxide technology show promise for hygiene control
|
|
NOLabs, the Swedish company developing innovative nitric oxide-containing medical devices based on the NitroSense Technology, has achieved important milestone in the development of a new range of products for wounds infected by MRSA-bacteria. |
|
|
Bristol-Myers Squibb launches clinical centre for children's immune system disorders and infectious diseases
|
|
Bristol-Myers Squibb has joined Robert Wood Johnson University Hospital to launch a new clinical centre at The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital. |
|
|
APIC introduces new programme to help eradicate HAIs
|
|
The Association for Professionals in Infection Control and Epidemiology (APIC) has introduced a new series of educational initiatives aimed at eliminating healthcare-associated infections (HAIs). |
|
|
First molecular test is launched in Europe to identify SA and MRSA from nasal and wounds specimens
|
|
BD Diagnostics is launching the BD GeneOhm StaphSR assay for nasal and wound specimens as a CE marked product under the European In Vitro Diagnostics Directive. |
|
|
UCLH research study shows rapid screening for MRSA can cut hospital infections by 40 percent
|
|
University College London Hospital NHS Foundation Trust (UCLH) has published a major research study that demonstrates rapid screening for meticillin-resistant Staphylococcus aureus (MRSA) could help reduce hospital infection rates by almost 40 per cent. |
|
|
Royal Wolverhampton Hospitals NHS Trust wins infection control team prize
|
|
The first prize in the 2006/2007 Oxoid Infection Control Team of the Year Award has been won by the Royal Wolverhampton Hospitals NHS Trust in the UK. |
|
|
Two-hour assay identifies SA and MRSA in patients with positive blood cultures
|
|
BD Diagnostics has received US FDA clearance for the BD GeneOhm StaphSR assay, which is the first test available to rapidly and simultaneously identify two deadly healthcare-associated infections (HAIs) - Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) - from patien |
|
|
Cepheid begins shipping next generation molecular diagnostic systems
|
|
Cepheid has begun to ship the next generation GeneXpert Systems including the new GX-I single module system featuring a six-colour optical capability that enables detection of up to 60 individual targets in a single cartridge. |
|
|
Vernacare invests £1.5 million to automate production of infection control equipment
|
|
Vernacare has invested £1.5 million in automating its Bolton factory to boost efficiency, improve quality and increase capacity for export growth. |
|
|
Health Canada issues medical device licence for Cepheid’s Xpert MRSA test
|
|
Health Canada has issued a medical device licence for Cepheid’s Xpert MRSA test for the rapid detection of Methicillin Resistant Staphylococcus aureus (MRSA) on nasal swabs and the GeneXpert System. |
|
|
New polymer material stops bone bleeding and reduced surgical infection risks
|
|
Ostene, a new polymer material developed by Ceremed to stop bone bleeding in surgery has been shown to reduce the risk of surgical infection according to a new research study. |
|
|
New ultra thin multi-functional antimicrobial coating is durable and kills E.coli quickly
|
|
4MED is an innovative hygiene coating developed by Nano Hygiene Coatings that combines the benefits of the easy-to-clean properties derived from nano chemical technology with an antimicrobial additive to actively prevent the growth of bacteria such as Escherichia Coli and MRSA. |
|
|
Seal Shield begins to ship Silver Seal Washable, Antimicrobial Keyboard
|
|
Seal Shield has begun shipping the new Silver Seal Washable, Antimicrobial Keyboard which is the world's first computer keyboard to be fully submersible, dishwasher safe, and manufactured from Silver Seal Antimicrobial plastic. |
|
|
Surface disinfectant comes in new easy-to-use flat pack design
|
|
Metrex Research has introduced the newest member of its surface disinfection range, CaviWipes, in a flat pack that offers a new easy-open/easy-close pull tab with slim, flexible packaging and adhesive-backed strips. |
|
|
First UK panel is established to study antibacterial properties of silver in hospitals
|
|
BioCote has set up the UK’s first expert panel to study the antibacterial properties of silver, and further its use in hospitals. |
|
|
AcroMetrix launches first liquid MRSA positive control
|
|
AcroMetrix has launched the OptiQual MRSA Positive Control which is the first standardised external quality control for Methicillin Resistant Staphylococcus aureas (MRSA) molecular testing. |
|
|
Healthcare furniture manufacturer focuses on back care provision
|
|
Healthcare and leisure furniture manufacturer James Spencer has engaged Anne Lofthouse, an advisor from the College of Occupational Therapists Consultancy Service (COTCS) to evaluate and offer product development advice - particularly from a back care perspective. |
|
|
Cepheid selected to support CHA with MRSA test solution
|
|
Connecticut Hospital Association (CHA) Shared Services Program has been selected Cepheid as the vendor of choice for molecular surveillance testing of Methicillin-resistant Staphylococcus aureus (MRSA) with Cepheid's GeneXpert Systems and Xpert MRSA test. |
|
|
PCMH reports reductions in VAP rates due to MRSA
|
|
Pitt County Memorial Hospital (PCMH) has released preliminary data suggesting a statistically significant reduction in the rate of ventilator-associated pneumonia (VAP) due to methicillin-resistant Staphylococcus aureus (MRSA) in the surgical intensive care unit (SICU) with the implementation of an |
|
|
Cardinal Health funds major patient safety hospital programmes across the USA
|
|
Cardinal Health has awarded grants totalling $1 million for new and innovative programmes at 34 US hospitals, health systems and community health clinics. |
|
|
Worcester Acute NHS Trust wins major Infection Control Award
|
|
Worcester Acute NHS Trust, UK, has won the 2007/2008 Oxoid Infection Control Team of the Year Awards. |
|
|
New infection control keyboard helps combat HAIs
|
|
Devlin Electronics has released the new KCR-106-6XX infection control keyboard in the company’s healthcare range which is specifically designed to help health services tackle the problems of hospital acquired infections. |
|
|
Cepheid agrees Group Purchasing deal with Premier
|
|
Cepheid has signed a group purchasing contract with Premier, one of the largest US Group Purchasing Organizations (GPOs) with more than 1,500 participating hospitals and 42,000 other healthcare sites. |
|
|
Cepheid agrees group purchasing contract with Novation
|
|
Cepheid has signed a contract with Novation, the industry's leading contracting services company serving VHA, University HealthSystem Consortium (UHC) and Provista. |
|
|
Cleaning and disinfecting wipe eradicates five major pathogen groups
|
|
Vernacare has unveiled a new cleaning and disinfecting wipe that is kind to the hands, yet eradicates the major five major groups of pathogens, including C diff, MRSA and E Coli. |
|
|
First cartridge-based patient ID solution makes wristband printing easier and safer
|
|
The first cartridge-based patient ID solution to make wristband printing easier and more cost-effective for healthcare organizations has been unveiled by Zebra Technologies. |
|
|
Clinical trial finds Medihoney wipes out MRSA from chronic venous ulcers
|
|
A large randomized controlled clinical trial has found that Derma Sciences’ Medihoney Wound and Burn Dressing with Active Leptospermum Honey significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA) in chronic wounds. |
|
|
BD GeneOhm Cdiff molecular assay receives CE mark
|
|
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), has received the CE marking of the BD GeneOhm Cdiff molecular assay for the rapid diagnosis of patients with Clostridium difficile infection (CDI). |
|
|
Zeus offers rapid nasal screening test for MRSA
|
|
Zeus Scientific is to offer a rapid nasal screening test for methicillin-resistant Staphylococcus aureus (MRSA) based upon Zeus' own proprietary technology utilising the enrichment and nucleic acid amplification of a target pathogen. |
|
|
Vernacare prepares to unveil new macerator that eradicates five major pathogens
|
|
September’s Infection Prevention Society Conference will mark the official launch of Vernacare’s new Vortex macerator, and its powerful Tuffie 5 wipes - which eradicate the major five major groups of pathogens, including Cdiff, MRSA and E Coli. |
|
|
Seal Shield starts shipping keyboards with antimicrobial protection
|
|
Seal Shield has begun shipping a new family of fully submersible, 108 key, international keyboards with Silver Seal Antimicrobial protection to help reduce the risk of worldwide cross contaminations, including Norovirus and MRSA. |
|
|
Winners of the Oxoid Infection Control Team of the Year Awards receive their prizes
|
|
Oxoid has presented the winners of the 2007/2008 Oxoid Infection Control Team of the Year Awards with their prizes at a celebratory dinner, held in honour of the winners, at Walton Hall Hotel, Wellesbourne, Warwickshire, UK. |
|
|
Seal Shield launches antimicrobial flexible keyboard for mobile applications
|
|
Seal Shield has introduced the Silver Seal Flex Keyboard, the world's first keyboard that is fully submersible, dishwasher safe, antimicrobial and glows in the dark. |
|
|
John Radcliffe Hospital lays down eye catching flooring to help patient safety
|
|
An innovative floor graphics system from MacDermid Autotype is enabling patients and visitors at the new eye unit at John Radcliffe Hospital in Oxford to find their way around easily and safely. |
|
|
Bedford Hospital NHS Trust trials single-use washbowls to reduce infection risks
|
|
Bedford Hospital NHS Trust has teamed up with Vernacare to reduce the risk of cross infection from the use of shared plastic washbowls. |
|
|
Enigma Diagnostics receives £1.8 million grant to develop PRADA molecular test system
|
|
Enigma Diagnostics has been awarded a grant of £1.8 million from the UK Government’s Technology Strategy Board under the 'Technologies for Health’ programme. |
|
